Medication-Attributable Adverse Events in Heart Failure Trials

By sjmartinez • March 8, 2023

Harrington J, Fonarow GC, Khan MS, Hernandez A, Anker S, Böhm M, Greene SJ, Felker GM, Vaduganathan M, Butler J. Medication-Attributable Adverse Events in Heart Failure Trials. JACC Heart Fail. 2023 Jan 12:S2213-1779(22)00721-1. doi: 10.1016/j.jchf.2022.11.026. Epub ahead of print. PMID: 36881395.

Tags: Adverse events, Cardiology/Epi, Guideline-directed medical therapy, heart failure, Publications

Related Posts

Intensive Versus Standard Blood Pressure Control After Endovascular Thrombectomy in Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials

Hashmi TM, Ahmed M, Ashraf H, Shakir M, Bhatti IA, Ahmed F, Alareed A, Hasan A, Ahmed R, Rafiq S, Aized MT, Fonarow GC, Hassan[...]

p21+TREM2+ senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease

Salladay-Perez IA, Avila I, Estrada L, Alexandru AC, Ponce C, Dhingra A, Torres G, Deng CY, Hegde R, Gensheimer J, Kale A, Heckenbach I, Hui[...]

InChagas: Feasibility Study of a Tele-Education Strategy to Promote Early Identification and Care of People Living with Chagas Cardiomyopathy in an Endemic Community in Argentina

Gulayin PE, Gimenez C, Chirino D, Nascimento B, Salvá L, Cavallo AS, Gutierrez L, Blanco L, Flores LPC, Espina E, Shakil SS, Vervoort D, Davis[...]